Medicare Advantage enrollees who receive nonrenewal notices for contract year 2027 will gain a federally protected right to purchase any Medigap policy without medical underwriting. That protection, rooted in federal statute and enforced through CMS guidance, gives affected beneficiaries a strict 63-day window after their coverage ends to lock in supplemental insurance. With the Contract Year 2027 Medicare Advantage and Part D Final Rule now finalized, the scale of upcoming plan changes could push large numbers of beneficiaries into the Medigap market at once, particularly in counties where Medicare Advantage enrollment runs high.
Why 2027 MA plan exits create an urgent Medigap deadline
When a Medicare Advantage organization terminates a plan or pulls out of a service area, enrollees do not simply lose coverage and fend for themselves. Federal law activates a specific set of protections. Under Section 1395ss of the U.S. Code, beneficiaries displaced by a plan exit receive guaranteed-issue rights to buy standardized Medigap policies. Insurers cannot reject them, charge higher premiums based on health status, or impose waiting periods for pre-existing conditions during this window.
The clock, however, is unforgiving. Beneficiaries must apply no later than 63 days after their MA coverage ends, according to longstanding CMS guidance in the CMS fact sheet on Medicare plan options. Miss that deadline, and the guaranteed-issue right expires. At that point, Medigap insurers in most states can apply medical underwriting, which could mean denial of coverage or sharply higher premiums for anyone with chronic conditions.
The practical question for 2027 is whether this protection will be tested at a scale that strains the market. If a large number of MA plans exit or reduce service areas under the new final rule, counties with the highest MA penetration rates will likely see the most concentrated demand for Medigap policies. That spike could show up in state insurance department filings and CMS enrollment data within months of the annual notice period, though no official count of affected beneficiaries has been published yet. In areas where only a few Medigap insurers are active, a sudden wave of applications could also influence pricing strategies for future plan years, even if carriers must treat 2027 nonrenewal enrollees on a guaranteed-issue basis.
Federal rules and the CY2027 final rule behind guaranteed-issue rights
The legal architecture behind these protections runs through two connected statutes. Section 1882 of the Social Security Act governs Medicare supplemental policies and establishes the standardization framework that makes Medigap plans comparable across insurers. That statute works alongside the U.S. Code provision to define exactly which plans a displaced enrollee can buy and under what terms, including rules on benefits, renewability, and how insurers must treat eligible applicants during guaranteed-issue periods.
On the MA side, federal regulations at 42 CFR 422.62 spell out the special election periods triggered when CMS or an MA organization terminates a plan or changes its service area. These election periods are the mechanism that connects a plan exit to the beneficiary’s right to choose new coverage, whether that means joining another MA plan or returning to Original Medicare with or without a Medigap policy. The Contract Year 2027 final rule does not rewrite the core guaranteed-issue framework, but by tightening oversight of MA benefit design and marketing, it may indirectly increase the number of plans that decide not to renew contracts or that scale back in certain counties.
For beneficiaries, the interaction of these rules can be confusing. The MA special election period determines when they can switch plans or move back to Original Medicare, while the Medigap guaranteed-issue window determines how long they can secure supplemental coverage without underwriting. In practice, these timelines often overlap but are not identical, which is why the 63-day Medigap deadline is so critical for anyone leaving a nonrenewing MA plan. State regulators and consumer counselors will likely emphasize this distinction as 2027 notices go out.
What affected beneficiaries should watch for
Enrollees in MA plans that will not renew for 2027 should expect a written notice from their plan well before coverage ends, explaining the termination and outlining options. That notice, combined with the annual fall open enrollment period, is the first signal that a guaranteed-issue right may soon apply. Beneficiaries who want Medigap coverage should begin comparing standardized plans as soon as they learn of a nonrenewal, rather than waiting until after their MA coverage terminates.
Because Medigap policies are sold by private insurers and regulated at both federal and state levels, availability and pricing can vary widely by location. In some states, additional consumer protections extend beyond the federal baseline, while others follow the minimum guaranteed-issue scenarios tied to MA plan terminations and certain trial rights. Regardless of local variations, the federal 63-day protection for those losing MA coverage due to plan nonrenewal remains a key backstop for older adults and people with disabilities who rely on predictable out-of-pocket costs.
As the Contract Year 2027 landscape takes shape, stakeholders will be watching how many beneficiaries exercise these rights and whether Medigap markets absorb the influx smoothly. For now, the message to affected enrollees is straightforward but time-sensitive: if your Medicare Advantage plan does not renew for 2027 and you want Medigap coverage, the law gives you a powerful but temporary right to buy it-one that disappears just 63 days after your prior coverage ends.
Free for readers: The free Retirement Shield newsletter sends plain-English help keeping more of your money in retirement — the scams to dodge, the benefits you’re owed, and what’s changing with Social Security and Medicare, a couple times a week. Get the free newsletter.
